Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Non-Current Debt (2016 - 2025)

Fresenius Medical Care AG (FMS) has 15 years of Non-Current Debt data on record, last reported at $6.7 billion in Q4 2024.

  • For Q4 2024, Non-Current Debt changed N/A year-over-year to $6.7 billion; the TTM value through Dec 2024 reached $6.7 billion, changed N/A, while the annual FY2024 figure was $6.8 billion, N/A changed from the prior year.
  • Non-Current Debt reached $6.7 billion in Q4 2024 per FMS's latest filing, up from $852.4 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $8.1 billion in Q4 2020 and bottomed at $852.4 million in Q4 2022.
  • Average Non-Current Debt over 4 years is $5.8 billion, with a median of $7.1 billion recorded in 2021.
  • Peak YoY movement for Non-Current Debt: rose 13.42% in 2020, then plummeted 88.79% in 2022.
  • A 4-year view of Non-Current Debt shows it stood at $8.1 billion in 2020, then decreased by 6.21% to $7.6 billion in 2021, then tumbled by 88.79% to $852.4 million in 2022, then soared by 684.86% to $6.7 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $6.7 billion in Q4 2024, $852.4 million in Q4 2022, and $7.6 billion in Q4 2021.